Immunospecific regression of various syngeneic mouse tumors in response to neuraminidase-treated tumor cells
Rios, A.; Simmons, R.L.
Journal of the National Cancer Institute 51(2): 637-644
1973
ISSN/ISBN: 0027-8874 PMID: 4765377 Document Number: 60224
Document emailed within 1 workday
Related Documents
Sedlacek, H.H.; Seiler, F.R. 1977: Spontaneous mammary tumors in mongrel dogs. a relevant model to demonstrate tumor therapeutical success by application of neuraminidase-treated tumor cells Developments in Biological Standardization 38: 399-412Sethi, K.K.; Teschner, M. 1974: Neuraminidase induced immunospecific destruction of transplantable experimental tumors Postepy Higieny i Medycyny Doswiadczalnej 28(1): 103-120
Rohrer, J.W.; Rohrer, S.D.; Barsoum, A.; Coggin, J.H. 1994: Differential recognition of murine tumor-associated oncofetal transplantation antigen and individually specific tumor transplantation antigens by syngeneic cloned BALB/c and RFM mouse T cells Journal of Immunology 152(2): 754-764
Ogasawara, M.; Takebe, T.; Ishii, K. 1988: Tumor-associated antigen defined by a monoclonal antibody against neuraminidase-treated human cancer cells Cancer Research 48(2): 412-417
Rejthar, A. 1974: Detection of tumor-associated transplantation antigen of BO-IV carcinoma on somatic cells of tumor-free syngeneic mice. IV. Search for this antigen on syngeneic embryonic tissues Folia Biologica 20(4): 252-257
Sparks, F.C.; Breeding, J.H. 1974: Tumor regression and enhancement resulting from immunotherapy with Bacillus Calmette-Guérin and neuraminidase Cancer Research 34(12): 3262-3269
Bernstein, I.D.; Wright, P.W.; Cohen, E. 1976: Generation of cytotoxic lymphocytes in vitro: response of immune rat spleen cells to a syngeneic gross virus-induced lymphoma in mixed lymphocyte-tumor culture Journal of Immunology 116(5): 1367-1372
Rossowska, J.; Pajtasz-Piasecka, E.; Szyda, A.; Zietara, N.; Duś, D. 2007: Tissue localization of tumor antigen-loaded mouse dendritic cells applied as an anti-tumor vaccine and their influence on immune response Folia Histochemica et Cytobiologica 45(4): 349-355
Stillström, J. 1970: Immunization of mouse against SV 40 induced syngeneic tumor Acta Pathologica et Microbiologica Scandinavica. Section B: Microbiology and Immunology 78(2): 268
Shiio, T.; Ohishi, K.; Tsuchiya, Y.; Niitsu, I.; Hayashibara, H.; Yoshihama, T.; Moriyuki, H. 1988: Combined use of lentinan with X-ray therapy in an experimental mouse tumor system (Part 2). Combined effect on the MM102 syngeneic tumor Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(3): 475-479
Shimada, S.; Yano, O.; Inoue, H.; Kuramoto, E.; Fukuda, T.; Yamamoto, H.; Kataoka, T.; Tokunaga, T. 1985: Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors Journal of the National Cancer Institute 74(3): 681-688
Nakano, K.; Masuda, T. 1983: Involvement of carbohydrate moieties in the expression of effector activity of cytotoxic T cells against syngeneic tumor cells Gan 74(4): 568-575
Tomita, Y.; Himeno, K.; Nomoto, K.; Endo, H.; Hirohata, T. 1987: Augmentation of tumor immunity against syngeneic tumors in mice by beta-carotene Journal of the National Cancer Institute 78(4): 679-681
Saito, M.; Yamazaki, M.; Mizuno, D. 1978: Immune response of mice in immunotherapy of tumors with syngeneic antitumor serum plus lipopolysaccharide Gan 69(3): 331-337
Simmons, R.L.; Rios, A. 1973: Neuraminidase treated cells and their role in cancer immunotherapy Birth Defects Original Article Series 9(2): 223-228
Chida, K.; Kuroki, T. 1984: Inhibition of DNA synthesis and sugar uptake and lack of induction of ornithine decarboxylase in human epidermal cells treated with mouse skin tumor promoters Cancer Research 44(3): 875-879
Katoh, H. 1982: Immunological regression of metastatic tumor cells after surgical excision of primary tumor Hokkaido Journal of Medical Science 57(1): 37-46
Bratus', G.G.; Naumenko, O.I.; Nastenko, E.P.; Novichenko, N.L. 1990: The morphofunctional characteristics of lymphoma NK/LY cells treated with concanavalin a and Vibrio cholerae neuraminidase Tsitologiia 32(1): 67-73
Ray, P.K.; Gewurz, H.; Simmons, R.L. 1972: The serologic behaviour of neuraminidase-treated lymphoid cells. Alloantigenicity and complement sensitivity Clinical and Experimental Immunology 11(3): 441-460
Blazer, B.A.; Heppner, G.H. 1978: In situ lymphoid cells of mouse mammary tumors. II. the characterization of lymphoid cells separated from mouse mammary tumors Journal of Immunology 120(6): 1881-1886